5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile

C20H22N8 — CID 155323621

IUPAC5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile
SMILESCC12CN(c3cnc(C#N)cn3)CCC1CCN(c1ncnc3[nH]ccc13)C2
InChIInChI=1S/C20H22N8/c1-20-11-27(17-10-23-15(8-21)9-24-17)6-3-14(20)4-7-28(12-20)19-16-2-5-22-18(16)25-13-26-19/h2,5,9-10,13-14H,3-4,6-7,11-12H2,1H3,(H,22,25,26)
InChIKeyWCMRANDACFJKSR-UHFFFAOYSA-N
MW374.45 g/mol
LogP2.36
Rot. Bonds2

About 5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile

5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile (PubChem CID 155323621) has the molecular formula C20H22N8 and a molecular weight of 374.45 g/mol. Its IUPAC name is 5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile.

Molecular Properties

Compound Name5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile
PubChem CID155323621
Molecular FormulaC20H22N8
Molecular Weight374.45 g/mol
Exact Mass374.20
IUPAC Name5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile
SMILESCC12CN(c3cnc(C#N)cn3)CCC1CCN(c1ncnc3[nH]ccc13)C2
InChIInChI=1S/C20H22N8/c1-20-11-27(17-10-23-15(8-21)9-24-17)6-3-14(20)4-7-28(12-20)19-16-2-5-22-18(16)25-13-26-19/h2,5,9-10,13-14H,3-4,6-7,11-12H2,1H3,(H,22,25,26)
InChIKeyWCMRANDACFJKSR-UHFFFAOYSA-N
XLogP2.36
TPSA97.62 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds2
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500374.45
LogP ≤ 52.36
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze 5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile?
The IUPAC name of 5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile (CID 155323621) is 5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile.
What is the SMILES notation for 5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile?
The canonical SMILES for 5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile is CC12CN(c3cnc(C#N)cn3)CCC1CCN(c1ncnc3[nH]ccc13)C2.
What is the InChIKey of 5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile?
The InChIKey is WCMRANDACFJKSR-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H22N8/c1-20-11-27(17-10-23-15(8-21)9-24-17)6-3-14(20)4-7-28(12-20)19-16-2-5-22-18(16)25-13-26-19/h2,5,9-10,13-14H,3-4,6-7,11-12H2,1H3,(H,22,25,26).
What are the key properties of 5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile?
5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile has a molecular weight of 374.45 g/mol, XLogP of 2.36, 2 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[8a-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,4,4a,5,6,8-hexahydro-1H-2,7-naphthyridin-2-yl]pyrazine-2-carbonitrile is sourced from PubChem (CID 155323621), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).